Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ARLZ

Aralez Pharmaceuticals (ARLZ) Stock Price, News & Analysis

Aralez Pharmaceuticals logo

About Aralez Pharmaceuticals Stock (NASDAQ:ARLZ)

Advanced Chart

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
N/A
52-Week Range
$0.02
$2.98
Volume
N/A
Average Volume
5.13 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARLZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aralez Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARLZ Stock News Headlines

Adrian Adams's Net Worth
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
Amneal Pharmaceuticals, Inc. (AMRX)
Aveo Pharmaceuticals
MGC Pharmaceuticals Ltd (MXCM)
See More Headlines

ARLZ Stock Analysis - Frequently Asked Questions

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) announced its earnings results on Thursday, November, 9th. The company reported ($0.37) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.39) by $0.02. The company's quarterly revenue was up 78.7% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aralez Pharmaceuticals investors own include Magnegas Applied Tchnlgy Sltns (MNGA), Redhill Biopharma (RDHL), Synergy Pharmaceuticals (SGYP), TransEnterix (TRXDW), Novavax (NVAX), Inovio Pharmaceuticals (INO) and Liquidmetal Technologies (LQMT).

Company Calendar

Last Earnings
11/09/2017
Today
9/07/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ARLZ
CIK
1660719
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:ARLZ) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners